For 60+ years, respiratory syncytial virus (RSV) vaccines have evaded scientists. But now that's changed [Sponsored]

The podcast discusses the availability of RSV vaccinations for older adults, highlighting the increased risk and severe outcomes of RSV in this age group. It explores the vulnerability of the aging body to RSV and recent advancements in prevention methods. The importance of knowing RSV risk factors and getting vaccinated is emphasized, with no out-of-pocket expenses for Medicare and commercially insured patients.